◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

PharmaCorp Rx Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 4.8M 4.4M 4.0M 4.4M 1.1M --
Operating Revenue 4.7M 4.3M 4.0M 4.4M 1.1M --
Cost Of Revenue 2.8M 2.6M 2.4M 2.7M 688,999 --
Gross Profit 2.0M 1.7M 1.6M 1.7M 415,424 --
Selling General And Administration 2.2M 1.9M 1.2M 1.1M 1.5M --
General And Administrative Expense 2.2M 1.9M 1.2M 1.1M 1.5M --
Depreciation And Amortization In Income Statement 222,331 188,639 187,459 191,563 75,883 --
Operating Expense 2.5M 2.1M 1.4M 1.3M 1.5M --
Operating Income -498,816 -330,682 228,166 358,167 -1.1M --
EBIT -408,277 -214,524 375,735 630,599 -963,140 --
Interest Expense 19,803 13,245 13,706 14,396 13,653 --
Interest Expense Non Operating 19,803 13,245 13,706 14,396 13,653 --
Interest Income 56,182 83,415 104,328 191,499 151,083 --
Interest Income Non Operating 56,182 83,415 104,328 191,499 151,083 --
Net Interest Income 36,379 70,170 90,622 177,103 137,430 --
Other Income Expense 34,357 32,743 43,241 80,933 1,200 --
Other Non Operating Income Expenses 34,357 32,743 43,241 80,933 1,200 --
Pretax Income -428,080 -227,769 362,029 616,203 -976,793 --
Tax Provision -18,902 157,958 107,730 -107,030 828.00 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -427,516 -384,069 241,913 721,210 -975,861 --
Net Income From Continuing Operation Net Minority Interest -427,516 -384,069 241,913 721,210 -975,861 --
Net Income Including Noncontrolling Interests -409,178 -385,727 254,299 723,233 -977,621 --
Minority Interests -18,339 1,656 -12,386 -- 1,760 -1,666
Net Income Common Stockholders -427,516 -384,069 241,913 721,210 -975,861 --
Net Income -427,516 -384,069 241,913 721,210 -975,861 --
EBITDA -185,946 -25,885 563,194 822,162 -887,257 --
Normalized EBITDA -185,946 -25,885 563,194 822,162 -887,257 --
Reconciled Depreciation 222,331 188,639 187,459 191,563 75,883 --
Basic EPS 0.00 0.00 0.00 -- -0.01 -0.01
Diluted EPS 0.00 0.00 0.00 -- -0.01 -0.01
Basic Average Shares 117.3M 117.3M 117.3M -- 113.2M 55.6M
Diluted Average Shares 117.3M 117.3M 125.2M -- 113.2M 55.6M
Tax Rate For Calcs 0.04 0.15 0.30 0.15 0.15 --
Normalized Income -427,516 -384,069 241,913 721,210 -975,861 --
Amortization -- -- 128,343 -- -- --
Amortization Of Intangibles Income Statement -- -- 128,343 -- -- --
Depreciation Amortization Depletion Income Statement 222,331 188,639 187,459 191,563 75,883 --
Depreciation Income Statement 222,331 188,639 59,116 230,121 75,883 --
Diluted NI Availto Com Stockholders -427,516 -384,069 241,913 721,210 -975,861 --
Net Income Continuous Operations -409,178 -385,727 254,299 723,233 -977,621 --
Net Non Operating Interest Income Expense 36,379 70,170 90,622 177,103 137,430 --
Other Gand A 901,996 721,086 379,760 700,859 359,545 --
Reconciled Cost Of Revenue 2.8M 2.6M 2.4M 2.7M 688,999 --
Salaries And Wages 1.3M 1.2M 828,630 419,685 1.1M --
Total Expenses 5.3M 4.7M 3.8M 4.0M 2.2M --
Total Operating Income As Reported -508,223 -336,032 222,601 352,218 -1.1M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 5.0M 9.6M 12.9M 12.9M 26.7M --
Cash Cash Equivalents And Short Term Investments 5.0M 9.6M 12.9M 12.9M 26.7M --
Cash Financial 5.0M 9.6M 12.9M 12.9M 26.7M --
Accounts Receivable 785,928 643,163 372,437 326,783 222,516 --
Receivables 785,928 643,163 372,437 326,783 222,744 --
Inventory 2.5M 1.7M 1.6M 1.3M 329,368 --
Prepaid Assets 188,169 56,464 32,153 48,026 64,412 --
Current Assets 8.5M 12.0M 15.0M 14.6M 27.3M --
Gross PPE 4.4M 4.1M 4.1M 4.1M 943,886 --
Accumulated Depreciation -195,834 -145,853 -106,450 -69,779 -34,316 --
Net PPE 4.2M 4.0M 4.0M 4.0M 909,570 --
Goodwill 14.0M 12.5M 11.5M 11.5M 1.9M --
Goodwill And Other Intangible Assets 22.0M 19.5M 16.5M 16.6M 3.9M --
Other Intangible Assets 8.0M 6.9M 5.0M 5.1M 1.9M --
Total Non Current Assets 31.2M 23.4M 20.5M 20.6M 4.8M --
Total Assets 39.7M 35.4M 35.4M 35.2M 32.1M --
Current Debt 404,682 75,412 75,412 75,412 75,412 --
Current Debt And Capital Lease Obligation 493,157 151,596 150,481 149,384 148,298 --
Accounts Payable 2.8M 2.0M 1.4M 1.5M 492,157 --
Payables 2.9M 2.0M 1.6M 1.5M 492,157 --
Payables And Accrued Expenses 2.9M 2.0M 1.6M 1.5M 492,157 --
Current Liabilities 3.3M 2.1M 1.7M 1.7M 640,455 --
Long Term Debt 3.1M 280,500 299,353 318,206 337,059 --
Long Term Debt And Capital Lease Obligation 3.8M 727,303 765,631 803,693 841,437 --
Long Term Capital Lease Obligation 679,889 446,803 466,278 485,487 504,378 --
Other Non Current Liabilities -- -- -- -1,000 -- --
Total Non Current Liabilities Net Minority Interest 6.2M 2.8M 2.9M 2.9M 1.4M --
Total Liabilities Net Minority Interest 9.5M 4.9M 4.6M 4.6M 2.0M --
Common Stock 31.7M 31.7M 31.7M 31.7M 31.5M --
Capital Stock 31.7M 31.7M 31.7M 31.7M 31.5M --
Additional Paid In Capital 879,801 674,733 674,733 674,733 1.1M --
Retained Earnings -2.6M -2.2M -1.8M -2.0M -2.8M --
Common Stock Equity 30.0M 30.2M 30.6M 30.3M 29.8M --
Stockholders Equity 30.0M 30.2M 30.6M 30.3M 29.8M --
Total Equity Gross Minority Interest 30.2M 30.4M 30.8M 30.6M 30.1M --
Minority Interest 233,336 233,213 234,869 222,483 252,432 --
Total Capitalization 33.1M 30.5M 30.9M 30.7M 30.2M --
Net Tangible Assets 8.0M 10.7M 14.1M 13.7M 25.9M --
Tangible Book Value 8.0M 10.7M 14.1M 13.7M 25.9M --
Working Capital 5.1M 9.8M 13.2M 12.9M 26.7M --
Invested Capital 33.5M 30.6M 31.0M 30.7M 30.2M --
Total Debt 4.3M 878,899 916,112 953,077 989,735 --
Share Issued 117.3M 117.3M 117.3M 117.3M 117.0M --
Ordinary Shares Number 117.3M 117.3M 117.3M 117.3M 117.0M --
Allowance For Doubtful Accounts Receivable -- -- -- -- -- 0.00
Buildings And Improvements 3.6M 3.4M 3.4M 3.4M 564,675 --
Capital Lease Obligations 768,364 522,987 541,347 559,459 577,264 --
Current Capital Lease Obligation 88,475 76,184 75,069 73,972 72,886 --
Current Deferred Assets -- -- -- 0.00 0.00 0.00
Dueto Related Parties Current -- -- -- -- -- 118,246
Gross Accounts Receivable -- -- -- -- -- 63,967
Income Tax Payable -- -- -- -- -- 9,300
Land And Improvements 270,275 270,275 270,275 270,275 -- --
Leases 309,067 309,067 309,067 309,067 309,067 --
Machinery Furniture Equipment 255,221 174,328 154,350 127,447 70,144 --
Non Current Deferred Liabilities 2.3M 2.1M 2.1M 2.1M 527,856 --
Non Current Deferred Taxes Liabilities 2.3M 2.1M 2.1M 2.1M 527,856 --
Non Current Prepaid Assets 5.0M -- -- -- -- --
Other Current Borrowings 404,682 75,412 75,412 75,412 75,412 --
Other Inventories 2.4M -- -- 1.3M -- --
Properties 0.00 0.00 0.00 0.00 0.00 --
Raw Materials 53,321 -- -- 44,254 -- --
Taxes Receivable -- -- -- -- 228.00 5,259
Total Tax Payable 10,954 20,766 152,492 10,521 -- 9,300
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 550,259 -186,826 129,534 1.1M -642,898 --
Cash Flow From Continuing Operating Activities 550,259 -186,826 129,534 1.1M -642,899 --
Depreciation And Amortization 222,331 188,639 187,459 191,563 75,883 --
Depreciation Amortization Depletion 222,331 188,639 187,459 191,563 75,883 --
Stock Based Compensation -- -- -- -448,231 -- --
Deferred Tax -47,158 -33,600 -34,011 -127,419 -8,270 --
Deferred Income Tax -47,158 -33,600 -34,011 -127,419 -8,270 --
Change In Working Capital 559,394 30,615 -291,919 761,020 -477,927 --
Changes In Account Receivables 185,785 -270,726 -45,654 -- -96,923 --
Change In Receivables 185,785 -270,726 -45,654 -- -77,505 --
Change In Inventory -324,865 -71,043 -308,484 -- -134,062 --
Change In Payables And Accrued Expense 829,679 396,695 46,346 -- -223,886 197,001
Change In Payable 829,679 396,695 46,346 -- -223,886 --
Change In Other Working Capital -- -- -- -- 0.00 --
Other Non Cash Items 19,803 13,245 13,706 14,395 13,654 --
Capital Expenditure -- -2.1M -26,903 -- -- --
Purchase Of PPE 2.1M -2.1M -26,903 0.00 0.00 --
Net PPE Purchase And Sale 2.1M -2.1M -26,903 0.00 0.00 --
Purchase Of Business -10.2M -- -- -14.9M -- --
Investing Cash Flow -8.2M -3.1M -26,903 -14.9M -2.1M --
Cash Flow From Continuing Investing Activities -8.2M -3.1M -26,903 -14.9M -2.1M --
Repayment Of Debt -61,020 -50,458 -50,672 -51,053 -40,740 --
Net Issuance Payments Of Debt 3.1M -50,458 -50,672 -51,053 -40,740 --
Issuance Of Capital Stock 0.00 -- -- 0.00 7.6M 19.7M
Net Common Stock Issuance 0.00 -- -- 0.00 7.6M 19.7M
Financing Cash Flow 3.1M -50,458 -50,672 -51,053 7.6M --
Cash Flow From Continuing Financing Activities 3.1M -50,458 -50,672 -51,053 7.6M --
Changes In Cash -4.5M -3.4M 51,959 -13.8M 4.9M --
Beginning Cash Position 9.6M 12.9M 12.9M 26.7M 21.8M --
End Cash Position 5.0M 9.6M 12.9M 12.9M 26.7M --
Free Cash Flow 2.6M -2.3M 102,631 1.1M -642,898 --
Amortization Cash Flow -- -- 128,343 -- 31,208 --
Amortization Of Intangibles -- -- 128,343 -- 31,208 --
Change In Account Payable 829,679 528,421 -95,625 -- -96,340 --
Change In Income Tax Payable 0.00 -131,726 141,971 -- -9,300 --
Change In Prepaid Assets -131,205 -24,311 15,873 -- -42,474 15,786
Change In Tax Payable 0.00 -131,726 141,971 -- -9,300 --
Common Stock Issuance 0.00 -- -- 0.00 7.6M 19.7M
Depreciation -- -- 59,116 -- 44,675 --
Long Term Debt Payments -61,020 -50,458 -50,672 -51,053 -40,740 --
Net Business Purchase And Sale -10.2M -- -- -14.9M -2.1M --
Net Income From Continuing Operations -409,179 -385,725 254,299 723,233 -977,623 --
Net Long Term Debt Issuance 3.1M -50,458 -50,672 -51,053 -40,740 --
Proceeds From Stock Option Exercised 0.00 -- -- 0.00 0.00 --
NEWS
Loading news...
TRENDING
Loading...